Related Experiment Video
Updated: Jan 7, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Succinylcholine Versus Rocuronium for Pediatric Rapid Sequence Intubation in the Emergency Department
Donna Mendez1, John Zatarain1, Krishna Paul1
1Departments of Emergency Medicine.
Insights
In pediatric emergency medicine, succinylcholine use during rapid sequence intubation (RSI) was associated with lower mortality compared to rocuronium. This finding suggests succinylcholine may be a preferred agent for pediatric RSI in the ED.
Area of Science:
- Pediatric Emergency Medicine
- Pharmacology
- Critical Care
Background:
- Neuromuscular blocking agents like succinylcholine and rocuronium are crucial for rapid sequence intubation (RSI) in emergency departments (ED).
- Limited research exists comparing the safety and efficacy of these agents specifically in pediatric populations undergoing RSI.
- Key outcomes of interest include mortality, post-traumatic stress disorder (PTSD), and malignant hyperthermia.
Purpose of the Study:
- To compare the outcomes of death, PTSD, and malignant hyperthermia in children receiving succinylcholine versus rocuronium for RSI in the ED.
- To identify potential differences in adverse events associated with these neuromuscular blocking agents in pediatric patients.
Main Methods:
- A retrospective analysis of the TriNetX database was conducted, including pediatric patients (≤17 years) undergoing ED intubation between 2004 and 2024.
- Patients received either succinylcholine or rocuronium as a paralytic agent, often in conjunction with etomidate or ketamine.
- Propensity matching was employed to control for demographic and pre-existing condition differences between the two cohorts.
Main Results:
- After propensity matching, 706 patients were analyzed in each cohort (succinylcholine vs. rocuronium).
- Children receiving succinylcholine demonstrated a significantly lower mortality rate (5.7% vs. 8.9%, P=0.019).
- No significant differences were observed in PTSD rates or malignant hyperthermia between the groups. Subgroup analysis indicated succinylcholine with etomidate as an optimal RSI drug combination.
Conclusions:
- Succinylcholine administration was associated with reduced mortality in pediatric patients undergoing RSI in the ED compared to rocuronium.
- The study suggests a potential benefit of succinylcholine for improving RSI outcomes in children.
- Further prospective research is warranted to confirm these findings and guide clinical practice.
Objectives:
Succinylcholine and rocuronium are neuromuscular blocking agents used in the emergency department (ED) during rapid sequence intubation (RSI). Very few studies have been conducted to determine which agent is preferred for children. This study analyzed outcomes of death, post-traumatic stress disorder (PTSD) and malignant hyperthermia for children administered succinylcholine versus rocuronium for RSI in the ED.
Methods:
This retrospective, propensity-matched study utilized the TriNetX database. Cohorts included children less than or equal to 17 years of age, given a paralytic agent plus etomidate or ketamine during intubation in the ED from 2004 to 2024. Cohorts were further stratified by the administration of succinylcholine or rocuronium. The outcomes measured were death, PTSD, and malignant hyperthermia. Propensity matching was done for demographics and pre-existing conditions.
Results:
Before propensity matching, 2095 pediatric patients were identified. After propensity matching, 706 patients were identified in each cohort. After propensity matching, children administered succinylcholine had a lower rate of death (5.7% vs. 8.9%, RR: 0.65, 95% CI [0.43-0.93], P =0.019) but no significant difference in PTSD (2.6% vs. 3.7%, RR: 0.71, 95% CI [0.32-1.68], P =0.399). There was no significant difference in malignant hyperthermia. Subgroup analysis suggests that succinylcholine and etomidate were the best combination of drugs for RSI.
Conclusions:
Mortality rates were lower for children administered succinylcholine for RSI when compared with rocuronium. This study demonstrates a potential association between succinylcholine use and favorable RSI outcomes in the ED, though further prospective studies are needed.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Therapeutic Uses
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Endotracheal Intubation I: Procedure
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...

